Cytokines are recognized to play an important role in acute stroke. Tumor necrosis factor-a (TNF) is one of the pro-inflammatory cytokines and is expressed in ischemic brain.
Animal models of ischemic tolerance induced by "preconditioning" offer the possibility to examine the mechanisms selected by nature to limit ischemic damage. Many kinds of pretreatment, such as sublethal ischemia (Kitagawa et aI., 1990; Kato et aI., 1991; Kirino et aI., 1991; Aoki et aI., 1993) , hyperthermia, and oxidative stress (Ohtsuki et aI., 1993) , are able to induce tolerance against delayed neuronal death after transient ischemia in rodents. The mechanisms of induced tolerance are not known precisely; however, several possible explanations exist, such as induction of heat shock proteins in neurons (Aoki et aI., 1993; Nowak and Jacewicz, 1994) and in creased expression of bcl-2 oncoprotein (Shimazaki et aI., 1994) .
In focal cerebral ischemia, such as permanent middle cerebral artery occlusion (MCAO), the ischemic core cannot be salvaged by any presently known means of treatment without reestablishment of cerebral blood flow. The border zone, or penumbra, can be salvaged by 483 0.5 f.l,g/mouse (p < 0.0 I) intracisternally. At the doses used in this study, administration of TNF by intravenous or intraperi toneal routes was not effective. Immunohistochemical analysis of brains subjected to 24 h of MCAO revealed a significant decrease in CD 11 b immunoreactivity after TNF pretreatment compared with control MCAO. Preconditioning with TNF af fects infarct size in a time-and dose-dependent manner. TNF induces significant protection against ischemic brain injury and is likely to be involved in the signaling pathways that regulate ischemic tolerance. Key Words: Brain infarction-Ischemic tolerance-Leukocyte-Microglia-Tumor necrosis factor. several kinds of treatment. One of the factors affecting the fate of the penumbra is thought to be a gradually progressing disturbance in microcirculation. Excitotox icity, energy imbalance due to ischemic depolarization, free radical injury including synthesis of nitric oxide, and inflammatory reactions that include leukocyte infiltration may affect outcome of the penumbra (Dalkara and Moskowitz, 1994; Hossmann, 1994; Garcia et aI., 1995; Siesjo et aI., 1995) . We have observed that systemic administration of lipopolysaccharide (LPS) can induce ischemic tolerance in spontaneously hypertensive rats subjected to permanent MCAO. Co-administration of TNF binding protein (Amgen, Boulder, CO, U.S.A.) with LPS blocked acquisition of ischemic tolerance in that model (Tasaki et aI., 1997) .
TNF is one of the pro-inflammatory cytokines and is expressed in ischemic brain (Liu et aI., 1994) . TNF stimulates acute-phase protein production in the liver (Guy et aI., 1991; Marino et aI., 1991) , enhances perme ability of the blood-brain barrier, and induces expression of endothelial adhesion molecules and release of inflam matory mediators from macrophages, endothelial cells, and glial cells (Briscoe et aI., 1992; Feuerstein et aI., 1994) . TNF also activates or induces synthesis or gene expression of manganese superoxide dismutase in mito chondria (Suzuki et aI., 1993; Mokuno et aI., 1994) , up-regulates nitric oxide synthetase in endothelial cells (Tu reen, 1995) , and induces growth factors from astrocytes contributing to neuronal survival after insults (Donato et ai., 1989; Feuerstein et ai., 1994) .
Induction of tolerance by TNF and interleukin-l against a subsequent ischemic insult has been reported in the heart and lung (Colletti et ai., 1994) but not in the brain. In this study we investigated a role of TNF in acquisition of tolerance to ischemic brain damage.
MATERIALS AND METHODS

Experimental groups
Mature male BALB/C mice, weighing 22-26 g, were used. Sixty-one mice were divided into 10 experimental groups.
MCAO was performed without any pretreatment in the "con trol" group (n = 8). In the "vehicle i.p." group (n = 6), mice were pretreated by intraperitoneal injection of vehicle [phos phate-buffer�d saline (PBS) with 50 j.Lg/ml of LPS-free bovine serum albumin (BSA)]. In the "TNF 40 j.Lg/kg i.p." (n = 6) and the "TNF 200 j.Lg/kg i.p." (n = 5) groups, mice were pretreated by an intraperitoneal injection of an appropriate dose of TNF. In the "vehicle i.v." group (n = 7), mice were pre treated by an intravenous injection of vehicle (PBS with 50 j.Lg/ml of LPS-free BSA). In the "TNF 40 j.Lg/kg i.v." group (n = 7) and the "TNF 200 j.Lg/kg i.v." group (n = 2), mice were pretreated by an intravenous injection of an appropriate dose of TNF. In the "vehicle cisternal" group, mice (n = 7) were pretreated by an intracisternal injection of vehicle (PBS with 50 j.Lg/ml of LPS-free BSA). In the' 'TNF 0.05 j.Lg cisternal" (n = 7) and the "TNF 0.5 j.Lg cisternal" group (n = 6), mice were pretreated by an intracisternal injection of the appropriate dose of TNF. of LPS-free BSA). Forty-eight hours later, left MCAO was performed in animals as described herein.
Preconditioning by mouse recombinant TNF
Permanent MCAO in mice
Animals were anesthetized with 3% halothane for induction and 1.5% halothane for maintenance in 30% O2/70% N20 via a face mask. The rectal temperature was measured and main tained at 37 ± 0.2°C with a heating blanket. The exposure of the MCA was based on the description by Welsh et al. (1987) .
Briefly, the left temporoparietal region of the head was shaved and a 5-mm incision was made between the orbit and ear.
Under an operating microscope, an incision was made by di viding the temporal muscle, and the left lateral aspect of the skull was exposed by reflecting the temporal muscle and sur rounding soft tissue. A small burr hole (I mm) was made using a high-speed microdrill, through the outer surface of the semi translucent skull just over the visibly identified MCA at the level of the inferior cerebral vein. Saline was applied to the area throughout the procedure to prevent heat injury. The inner layer of the skull was removed with fine forceps, and left MCAO was performed by electrocoagulation, using a small vessel cauter izer directly through the dura without damaging the brain sur face. If the brain surface was visibly damaged or if the MCA was noted to bleed due to incomplete artery occlusion/ coagulation, the animal was killed and eliminated from the study. The muscle and soft tissue were replaced and the skin was closed using 5-0 nylon suture. The duration of anesthesia in all animals was <30 min. During anesthesia, the left femoral artery was catheterized using a P-1O tube for arterial blood sampling and continuous monitoring of arterial blood pressure.
Measurement of size of cortical infarcts using 2,3,5-triphenyltetrazolium chloride Twenty-four hours after MCAO, the animals were injected with a lethal dose of thiopental (150 mg/kg body mass i.p.); the brains were removed, cut into I-mm-thick coronal sections, and immersed in 2% 2,3,5-triphenyltetrazolium chloride saline so lution at 37°C for 30 min. The infarcted areas of the brain slice were measured using a computer-assisted image analyzing sys tem (NIH image 1.57). The infarct volume was calculated by taking the sum of the infarct areas of different brain slices times the thickness of the slices. The contribution of the edema vol ume to the infarct volume was corrected by subtracting the ipsilateral uninvolved hemisphere volume from the total con tralateral hemisphere volume and dividing by the total contra lateral hemisphere volume (Swanson et aI., 1990; Lin et aI., 1993) . Infarct volumes in each group were assessed by analysis of variance followed by Bonferroni/Dunn test to ascertain sig nificance between groups. Statistical significance was set at p < 0.05.
Histopathological and immunohistochemical evaluation
Twenty-four hours after MCAO with or without pretreat ment by cisternal 0.5 j.Lg of TNF, the animals were injected with a lethal dose of thiopental (150 mg/kg body mass i.p.) and fixed transcardially by perfusion with 4% paraformaldehyde in 150 mM NaCI and 50 mM sodium phosphate (pH 7.4). The brain was removed, stored in fixative for several hours, and then immersed in 20% sucrose solution in PBS for 1 day. The brains were then frozen in 2-methylbutane with dry ice. Coro nal sections at the level of the dorsal hippocampus that repre sented the midportion of the infarcts were cut on a cryostat at 
RESULTS
Preischemic physiological variables did not differ sig nificantly among the various groups of animals (Table  1 ). There was also no significant elevation of body tem perature or reduction of body weight following pretreat ment with TNF at any of the doses used in this study.
Volumes of brain damage (adjusted for the contribu tion of edema) were 29.5 ± 3.5 mm 3 in control animals (n = 8), 27.2 ± 3.7 mm 3 in vehicle i.p. (n = 6), 27.3 ± 3.0 mm 3 in TNF 40 ILg/kg i.p. (n = 6), 28.5 ± 2.7 mm 3 in TNF 200 ILg/kg i.p. (n = 5), 28.0 ± 4.7 mm 3 in vehicle i.v. (n = 7), 29.2 ± 4.8 mm 3 in TNF 40 ILg/kg i.v. (n = 7), 31.2 ± 0.8 mm 3 in TNF 200 ILg/kg i.v. (n = 2), 30.3 ± 4.0 mm 3 in vehicle cisternal (n = 7), 23.0 ± 9.9 mm 3 in TNF 0.05 ILg cisternal (n = 7), and 22.5 ± 3.6 mm 3 in TNF 0.5 ILg cisternal (n = 6) animals (values expressed as means ± SD) ( Fig. 1) . Pretreatment by cis ternal injection of TNF produced a significant reduction in infarct volume as compared with the values of vehicle cisternal animals. The reduction of the infarct size was 26% of control values in TNF 0.5 ILg cisternal animals and 24% in TNF 0.05 ILg cisternal animals. No dose dependent effect of TNF pretreatment was noted. There was no difference in the infarct size between TNF 40 ILg/kg i.p., TNF 200 ILg/kg i.p., and vehicle i.p. animals. There was also no difference between TNF 40 ILg/kg Lv., TNF 200 ILg/kg i.v., and vehicle i.v. animals. Represen tative photographs of brain slices in control vehicle cis ternal animals and TNF 0.5 ILg cisternal animals are shown in Fig. 2 . In the pretreated animals that received intracisternal TNF, border zones between anterior and middle cerebral arteries appeared to become more viable as compared with control animals. In perfusion-fixed brain slices, the infarcted area (mm 2 ) was also signifi cantly (p < 0.01 by analysis of variance followed by Bonferroni/Dunn test) smaller in the pretreatment group animals compared with the control MCAO (Fig. 3) . The reduction of the infarcted area was 27% of control values in the pretreated group animals. Immunohistochemical analysis of brains subjected to 24 h of MCAO revealed a significant decrease in CDllb immunoreactivity after TNF pretreatment (n = 4) com pared with control MCAO (n = 4) (Fig. 4) . The repre sentative immunohistochemical stainings for CD 11 b and GF AP of brain slices in control vehicle cisternal animals and TNF 0.5 /-Lg cisternal animals are shown in Fig. 5 . CDllb immunoreactivity was prominent in the ipsilat eral corpus callosum of all control MCAO animals, but only one of four animals in the pretreatment group showed CD 11 b immunoreactivity within the corpus cal losum. The CDllb immunostained cells were predomi nantly neutrophils and macrophages in the core of infarct and activated microglia in the periinfarct area as identi fied morphologically. The representative photomicro graphs of CD 11 b immunostaining in the infarcted area in both TNF-pretreated and control groups are shown in Fig. 6 . GFAP immunoreactivity increased significantly in the infarcted area in both TNF-pretreated and control groups with no significant difference between these two groups (Figs. 4 and 5) . F4/S0 immunoreactivity de creased significantly in both the core and the periinfarct areas in the TNF-pretreated group (n = 4) as compared with vehicle control group (n = 4) (Fig. 7) . The F4/S0 stains exclusively ramified microglial cells in the periin farct area and ameboid macrophages/microglia in the core of infarct. The representative photomicrographs of F4/S0 immunostaining in the periinfarct area in both TNF-pretreated and control groups are shown in Fig. S . TNF immunoreactivity increased significantly after MCAO in the infarcted area in both TNF-pretreated and control groups with no significant difference between these two groups (Figs. 4 and 9) . The type of TNF im munostained cell was exclusively macrophage and ame boid microglia by morphologic criteria. Some neurons were also positively immunostained for TNF. No dis- and glial fibrillary acidic protein (GFAP) in brain slices from con trol vehicle cisternal animals and tumor necrosis factor-a (TNF) 0.5 �g cisternal animals. CD1 1 b immunoreactivity was prominent in the ipsilateral corpus callosum of all control middle cerebral artery occlusion animals, but only one of four TNF-pretreated animals showed CD1 1 b immunoreactivity within the corpus cal losum. GFAP immunoreactivity increased significantly in the in farcted area in both TNF-pretreated and control groups with no significant difference between the two.
cernible immunoreactivity was noted when the primary antibody was omitted from any of the staining proce dures.
DISCUSSION
In this study, we investigated the effects of TNF pre treatment on the outcome of a subsequent MCAO in mice. We chose this model because distal MCAO can produce a relatively large cortical infarct with a small variation in BALB/C mice (Barone et aI., 1993) . Recom binant mouse TNF is a 17 -kDa protein that penetrates the intact blood-brain barrier at low levels. It has been re-ported that intravenous or intraperitoneal injection of LPS can elicit a rapid increase of TNF in serum but no prominent increase in cerebrospinal fluid (Hallenbeck et aI., 199 1; Siren et aI., 1993) . However, peripheral ad ministration of TNF, which can stimulate blood cells and endothelium, had no significant protective effects after permanent MCAO in the doses used in this study. To evaluate the central effect of TNF, we administered TNF intrathecally. Cisternal injection of TNF induced signifi cant protection against focal cerebral ischemia. We found no dose-dependent effect of TNF pretreatment. This may be because the doses chosen were maximal and a 26% reduction in infarct volume is all that TNF pre treatment can do in this model. The degree of neuropro tection, -25% reduction of control value, was smaller than that reported previously using the noncompetitive N-methyl-D-aspartate receptor antagonist MK-80 1 or us ing the immunosuppressive drug FK-506 in another spe cies (Sharkey and Butcher, 1994) . Cortical damage was reduced by 46% when FK-506 (1 mg/kg) was adminis tered 60 min postocclusion in rats (Sharkey and Butcher, 1994) . This may relate to species differences in addition to different mechanisms of action among the drugs. Some agents such as the spin-trapping agent a-phenyl N-t-butylnitrone appear less potent at reducing postisch emic brain injury volume in the mouse than in the rat (our unpublished data).
Neurons, astrocytes, and microglial and endothelial cells have both types of TNF receptors, p55 and p75, and all could participate in TNF-induced tolerance (Armit age, 1994; Beutler and Van Huffel, 1994) . Immunohis tochemical analysis of TNF expression demonstrated that TNF immunoreactivity increased significantly after MCAO in the infarcted area. However, TNF immunore activity was not different between the control and toler ant groups. Thus, down-regulation of TNF expression in pretreated animals appears not to be responsible for the pretreated (n = 4) and control (n = 4) animals. Optical densities in each group were compared by analysis of variance followed by the Bonferroni/Dunn test to ascertain significance between groups. Statistical significance was set at p < 0. 05. A significant decrease in F4/80 immunoreactivity in pretreated animals was noted in the core and periinfarct area. *p < 0. 05; **p < 0. 01 .
induced tolerance in this model. Secondary effects of TNF might play a role, however. One important inflam matory effect of TNF is up-regulation of adhesion mol ecules on l ndothelial cells (Briscoe et aI., 1992; Feuer stein et aI., 1994) . This facilitates migration of activated leukocytes into the ischemic brain and might result in secondary damage following brain ischemia (Kochanek and Hallenbeck, 1992; Hallenbeck, 1996) . In fact, TNF administered simultaneously with MCAO or 24 h before MCAO exacerbated focal ischemic injury (our unpub lished data; Barone et aI., 1996) .
To elucidate the role of leukocytes in TNF-induced tolerance, we examined expression of a leukocyte inte grin, Mac-l (CD 11 blCD 18), in the infarcted hemisphere. The immunohistochemical analysis of CDl 1b showed a significant decrease in its immunoreactivity after pre treatment by cisternal TNF when compared with control MCAO. The rat anti-mouse CD 11 b antibody recognizes the murine a-integrin chain, which exists as a heterodi mer with the 132-integrin (CDI8) on neutrophils and monocytes (Springer, 1990) . CDII b immunostaining suggests that leukocyte infiltration is reduced. In fact, a related finding is that leukocyte infiltration was lessened 48 h after cisternal injection of TNF (Fig. 6) . This seems to be a possible contributing mechanism for the acquisi tion of tolerance after intracisternal TNF. Since CD 11 bl CD 18 integrin is also expressed by macrophages and microglial cells, a role for these cells is also possible. Indeed the degree of immunoreactivity for F4/80 in mi croglial cells was lessened in the periinfarct area of tol erant animals ( Figs. 7 and 8 ). Excessive activation of microglial cells might exacerbate outcome during cere bral ischemia. The role of activated astrocytes in acqui sition of tolerance induced by TNF pretreatment may be small because the immunoreactivity for GF AP was very similar in the groups that received intracisternal TNF or vehicle prior to MCAO.
Our data, demonstrating a decrease of CD 11 b immu noreactivity and low leukocyte counts in the infarcted area of tolerant animals, are consistent with the recent observation that pretreatment of cultured endothelial cells with TNF for 72 h inhibited TNF-mediated activa tion of nuclear factor-KB (NF-KB) (Ferran et aI., 1995) . NF-KB is known to initiate transcription of the genes encoding ICAM-l on endothelial cells, a counterreceptor for leukocyte integrins. NF-KB activation is associated with protein phosphorylation that results from TNF bind ing to its receptor (Laegreid et aI., 1995) . There are re ports of TNF-mediated activation of serine kinases, mi crotubule-associated protein-2 kinases, cap-binding pro tein kinases, protein kinase C, and tyrosine kinases (Guy et aI., 199 1; Marino et aI., 199 1) . These intracellular necrosis factor-a (TNF) in brain slices from control vehicle cis temal animals and TNF 0. 5 I-Ig cisternal animals. TNF immuno reactivity increased significantly after middle cerebral artery oc clusion in the infarcted area in both TNF-pretreated ' and control groups with no significant difference between these two groups.
processes may participate in acquisition of tolerance against ischemia. In summary, our results indicate a role for TNF in the induction of tolerance to ischemia. Elucidation of mecha nisms that regulate the acquisition of such tolerance could guide efforts to develop effective measures to re duce ischemic injury.
